Cardinal Health, Inc.

CAH · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.3%

Institutions91.2%

Public / Other

Income Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Total money the company brought in from its core business during the period, before any costs are subtracted.	$222.58B	$226.83B	$205.01B	$181.36B	$162.47B	$152.92B	$145.53B	$136.81B	$129.98B	$121.55B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$214.41B	$219.41B	$198.12B	$174.82B	$155.69B	$146.05B	$138.70B	$129.63B	$123.43B	$115.00B
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$8.17B	$7.41B	$6.89B	$6.54B	$6.78B	$6.87B	$6.83B	$7.18B	$6.54B	$6.54B
Gross profit as a percentage of revenue.	3.7%	3.3%	3.4%	3.6%	4.2%	4.5%	4.7%	5.2%	5.0%	5.4%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$2.27B	$1.24B	$727.00M	-$596.00M	$472.00M	-$4.10B	$2.06B	$126.00M	$2.12B	$2.46B
Operating income as a percentage of revenue.	1.0%	0.5%	0.4%	-0.3%	0.3%	-2.7%	1.4%	0.1%	1.6%	2.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$8.00M	$1.00M	$1.00M	$1.00M	$1.00M	$3.00M	$1.36B	$256.00M	$6.00M	$1.43B
Net income divided by the number of shares outstanding — profit attributable to each share.	$6.48	$3.48	$1.00	$-3.35	$2.09	$-12.61	$4.00	$0.00	$4.00	$4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$6.45	$3.45	$1.00	$-3.35	$2.08	$-12.61	$4.00	$0.00	$4.00	$4.00

Balance Sheet

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Cash and highly liquid short-term investments the company can access almost immediately.	$3.87B	$5.13B	$4.04B	$4.72B	$3.41B	$2.77B	$2.53B	$1.76B	$6.88B	$2.36B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$53.12B	$45.12B	$43.42B	$43.88B	$44.45B	$40.77B	$40.96B	$39.95B	$40.11B	$34.12B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	-$2.78B	-$3.21B	-$2.85B	-$709.00M	$1.79B	$1.79B	$6.33B	$6.06B	$6.81B	$6.55B

Cash Flow Statement

	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$2.40B	$3.76B	$2.84B	$3.12B	$2.43B	$1.96B	$2.72B	$2.77B	$1.18B	$2.97B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$547.00M	$511.00M	$481.00M	$387.00M	$400.00M	$375.00M	$328.00M	$384.00M	$387.00M	$465.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$1.85B	$3.25B	$2.36B	$2.73B	$2.03B	$1.58B	$2.39B	$2.38B	$797.00M	$2.51B

	You	Peer avg
P/E	34.2	25.0
Revenue Growth	+5.8%	+8.1%
ROE	–	30.2%

Cardinal Health, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Related Market Insights

Stockinder Earnings Update: Key US Corporate Reporting Dates For August 11, 2026

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison